Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis (PCI)
Randomized Phase II Trial of Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma Clinical Stage IIIB and IV With High Risk of Brain Metastasis
Sponsor: Instituto Nacional de Cancerologia de Mexico
A NA clinical study on Lung Cancer, this trial is completed. The trial is conducted by Instituto Nacional de Cancerologia de Mexico and has accumulated 9 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — May 2023 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed
▶ Show 4 earlier versions
-
Apr 2019 — Aug 2020 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting NA
-
Mar 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Phase: PHASE2 → NA
-
Jan 2017 — Mar 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
May 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto Nacional de Cancerologia de Mexico
For direct contact, visit the study record on ClinicalTrials.gov .